2/21/24 18:13 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | S | -75 | 15.74 | 0 | -5 | -2 | 211 | D | | | | | | | | | | | | | | |
2/20/24 16:58 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Qatanani Mo | MA | O | CHIEF SC | S | -40 | 15.74 | 0 | -3 | -2 | 147 | D | | | | | | | | | | | | | | |
2/20/24 16:52 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Parlavecchio Caryn | MA | O | CHRO | S | -59 | 15.74 | 0 | -4 | -2 | 158 | D | | | | | | | | | | | | | | |
2/20/24 16:48 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Ho Junlin | MA | O | GC | S | -55 | 15.74 | 0 | -3 | -2 | 209 | D | | | | | | | | | | | | | | |
2/20/24 16:46 | 2/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Backstrom Jay T. | MA | DO | CEO | S | -183 | 15.74 | 0 | -12 | -3 | 353 | D | | | | | | | | | | | | | | |
1/18/24 16:11 | 1/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Qatanani Mo | MA | O | SVP,HEAD | S | -32 | 15.93 | 0 | -2 | -2 | 79 | D | | | | | | | | | | | | | | |
1/18/24 16:08 | 1/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Parlavecchio Caryn | MA | O | CHRO | S | -45 | 15.93 | 0 | -3 | -2 | 114 | D | | | | | | | | | | | | | | |
1/18/24 16:07 | 1/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | S | -106 | 15.93 | 0 | -7 | -4 | 162 | D | | | | | | | | | | | | | | |
1/18/24 16:05 | 1/16/24 | SRRK | Health | BioPrd | Biological Products, (No Diag | Ho Junlin | MA | O | GC | S | -67 | 15.93 | 0 | -4 | -3 | 154 | D | | | | | | | | | | | | | | |
12/29/23 19:13 | 12/29/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | M.d | 61 | 4.86 | 0 | 12 | 8 | 169 | D | | | | | | | | | | | | | | |
12/29/23 19:13 | 12/29/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | S.d | -235 | 18.83 | 0 | -12 | -7 | 169 | D | | | | | | | | | | | | | | |
12/15/23 16:13 | 12/14/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Qatanani Mo | MA | O | SVP,HEAD | M.d | 84 | 10.00 | 0 | 8 | 12 | 81 | D | | | | | | | | | | | | | | |
12/15/23 16:13 | 12/14/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Qatanani Mo | MA | O | SVP,HEAD | S.d | -448 | 18.18 | 0 | -25 | -23 | 81 | D | | | | | | | | | | | | | | |
12/8/23 16:12 | 12/7/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | M.d | 121 | 4.86 | 0 | 25 | 17 | 169 | D | | | | | | | | | | | | | | |
12/8/23 16:12 | 12/7/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | S.d | -437 | 17.53 | 0 | -25 | -13 | 169 | D | | | | | | | | | | | | | | |
11/3/23 18:11 | 11/2/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | COO,CFO | S | -438 | 12.51 | 0 | -35 | -17 | 169 | D | | | | | | | | | | | | | | |
10/18/23 17:46 | 10/16/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Akkaraju Srinivas | CA | DT | | P | 15,000 | 6.85 | 0 | 2,190 | 48 | 6,789 | I | | | | | | | | | | | | | | |
10/18/23 17:44 | 10/16/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Samsara Biocapital Gp, LLC | CA | T | | P | 15,000 | 6.85 | 0 | 2,190 | 48 | 6,789 | I | | | | | | | | | | | | | | |
10/16/23 17:46 | 10/12/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | | P | 15,087 | 6.86 | 0 | 2,200 | 24 | 11,259 | D | | | | | | | | | | | | | | |
9/20/23 19:28 | 9/18/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Qatanani Mo | MA | O | SVP,HEAD | S | -12 | 6.34 | 0 | -2 | -2 | 97 | D | | | | | | | | | | | | | | |
8/18/23 16:05 | 8/16/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Parlavecchio Caryn | MA | O | CHRO | S | -9 | 6.83 | 0 | -1 | -1 | 117 | D | | | | | | | | | | | | | | |
5/2/23 21:00 | 4/28/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | | P | 203 | 6.43 | 0 | 32 | 0 | 9,060 | D | | | | | | | | | | | | | | |
1/11/23 20:30 | 1/9/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | | S | -10 | 9.48 | 0 | -1 | 0 | 9,028 | D | | | | | | | | | | | | | | |
1/9/23 17:22 | 1/5/23 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | | P | 455 | 9.33 | 0 | 49 | 1 | 9,029 | D | | | | | | | | | | | | | | |
10/27/22 16:36 | 10/25/22 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | | P | 1,047 | 8.04 | 0 | 130 | 1 | 8,980 | D | | | | | | | | | | | | | | |
10/7/22 16:30 | 10/3/22 | SRRK | Health | BioPrd | Biological Products, (No Diag | Invus Public Equities, L.P. | NY | T | | P.m | 760 | 7.60 | 0 | 100 | 1 | 8,850 | D | | | | | | | | | | | | | | |
6/24/22 16:27 | 6/22/22 | SRRK | Health | BioPrd | Biological Products, (No Diag | Nashat Amir | MA | D | | P.d | 5,870 | 4.90 | 0 | 1,198 | | 214 | I | | | | | | | | | | | | | | |
11/15/21 21:28 | 11/11/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Myles Edward H | MA | O | CFO | S.dm | -2,751 | 35.14 | 0 | -78 | -76 | 24 | D | | | | | | | | | | | | | | |
10/5/21 08:15 | 10/1/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Flier Jeffrey S. | MA | D | | S | -185 | 30.89 | 0 | -6 | -21 | 22 | I | | | | | | | | | | | | | | |
9/21/21 16:46 | 9/20/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Flier Jeffrey S. | MA | D | | S | -17 | 34.09 | 0 | -1 | -5 | 9 | D | | | | | | | | | | | | | | |
7/28/21 16:17 | 7/26/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Flier Jeffrey S. | MA | D | | S | -190 | 31.66 | 0 | -6 | -18 | 28 | I | | | | | | | | | | | | | | |
3/17/21 17:03 | 3/15/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Gilman Michael | MA | D | | S | -308 | 65.59 | 0 | -5 | -11 | 37 | D | | | | | | | | | | | | | | |
2/11/21 07:14 | 2/8/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Gilman Michael | MA | D | | S | -117 | 65.06 | 0 | -2 | -4 | 42 | D | | | | | | | | | | | | | | |
1/28/21 21:53 | 1/26/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Carven Gregory John | MA | O | Head of | S.am | -1,300 | 57.26 | 0 | -23 | -41 | 33 | D | | | | | | | | | | | | | | |
1/28/21 17:48 | 1/26/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Gilman Michael | MA | D | | M.d | 20 | 5.77 | 0 | 4 | 9 | 44 | D | | | | | | | | | | | | | | |
1/28/21 17:48 | 1/26/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Gilman Michael | MA | D | | S.d | -207 | 59.26 | 0 | -4 | -7 | 44 | D | | | | | | | | | | | | | | |
1/28/21 17:47 | 1/26/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Carven Gregory John | MA | O | Head of | M.dm | 374 | 9.96 | 0 | 38 | | 27 | D | | | | | | | | | | | | | | |
1/28/21 17:47 | 1/26/21 | SRRK | Health | BioPrd | Biological Products, (No Diag | Carven Gregory John | MA | O | Head of | S.dm | -3,265 | 58.44 | 0 | -56 | -68 | 27 | D | | | | | | | | | | | | | | |
5/31/18 21:43 | 5/29/18 | SRRK | Health | BioPrd | Biological Products, (No Diag | Polaris Venture Management Co. Vi, L.L.C. | MA | T | | P.d | 2,000 | 14.00 | 0 | 143 | 5 | 2,833 | I | | | | | | | | | | | | | | |
5/31/18 21:42 | 5/29/18 | SRRK | Health | BioPrd | Biological Products, (No Diag | Nashat Amir | MA | DT | | P.d | 2,000 | 14.00 | 0 | 143 | 5 | 2,833 | I | | | | | | | | | | | | | | |
5/31/18 21:41 | 5/29/18 | SRRK | Health | BioPrd | Biological Products, (No Diag | Artal International S.C.A. | N4 | T | | P.d | 6,300 | 14.00 | 0 | 450 | 23 | 2,396 | M | | | | | | | | | | | | | | |
5/31/18 21:41 | 5/29/18 | SRRK | Health | BioPrd | Biological Products, (No Diag | Springer Timothy A | MA | DT | | P.d | 1,000 | 14.00 | 0 | 71 | 2 | 3,549 | M | | | | | | | | | | | | | | |